Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes

Virology

Volumn 223, Issue 1, 1996, Pages 198-207

  Mitchell, Bradley M ^a   Leung, Albert ^a   Stevens, Jack G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; LATENT VIRUS INFECTION; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS PATHOGENESIS;

EID: 0030245705     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0468     Document Type: Article

References (55)

1. Adler, S. P. (1983). Transfusion-associated cytomegalovirus infections. Rev. Infect. Dis. 5, 977-993.
2. Bale, J. F., Jr., and ONeil, M. E. (1989). Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection. J. Virol. 63, 2667-2673.
3. Balthesen, M., Messerle, M., and Reddehase, M. J. (1993). Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67, 5360-5366.
4. Brautigam, A. R., Dutko, F. J., Olding, L. B., and Oldstone, M. B. (1979). Pathogenesis of murine cytomegalovirus infection: The macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J. Gen. Virol. 44, 349-359.
5. Collins, T., Pomeroy, C., and Jordan, M. C. (1993). Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168, 725-729.
6. Collins, T. M., Quirk, M. R., and Jordan, M. C. (1994). Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J. Virol. 68, 6305-6311.
7. Cheung, K. S., and Lang, D. J. (1977). Transmission and activation of cytomegalovirus with blood transfusion: A mouse model. J. Infect. Dis. 135, 841-845.
8. Dankner, W. M., McCutchan, J. A., Richman, D. D., Hirata, K., and Spector, S. A. (1990). Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J. Infect. Dis. 161, 31-36.
9. Donovan, J., and Brown, P. (1991). Care and handling of lab animals. In "Current Protocols in Immunology" (J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, Eds.), p. 1.7.1. Greene Pub. and Wiley-Interscience, New York.
10. Dush, M. K., Sikela, J. M., Khan, S. A., Tischfield, J. A., and Stambrook, P. J. (1985). Nucleotide sequence and organization of the mouse adenine phophoribosyltransferase gene: Presence of a coding region common to animal and bacterial phophoribosyltransferases that has a variable intron/exon arrangement. Proc. Natl. Acad. Sci. USA 82, 2731-2735.
11. Duwall, C. P., Casazza, A. R., Grimley, P. M., Carbone, P. P., and Rowe, W. P. (1966). Recovery of cytomegalovirus from adults with neoplastic disease. Ann. Intern. Med. 64, 531-541.
12. Einhorn, L., and Ost, A. (1984). Cytomegalovirus infection of human blood. J. Infect. Dis. 149, 207-214.
13. Fiala, M., Payne, J. E., Berne, T. V., Moore, T. C., Henle, W., Montgomerie, J. Z., Chatterjee, S. N., and Guze, L. B. (1975). Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J. Infect. Dis. 132, 421-433.
14. Gerna, G., Zipeto, D., Parea, M., Revello, M. G., Silini, E., Percivalle, E., Zavattoni, M., Grossi, P., and Milanesi, G. (1991). Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J. Infect. Dis. 164, 488-498.
15. Grefte, A., van der Giessen, M., van Son, W., and The, T. H. (1993). Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J. Infect. Dis. 167, 270-277.
16. Henry, S. C., and Hamilton, J. D. (1993). Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice. J. Infect. Dis. 167, 950-954.
17. Henson, D., Smith, R. D., and Gehrke, J. (1966). Nonfatal mouse cytomegalovirus hepatitis. Am. J. Pathol. 49, 871-888.
18. Hirsch, M. S. (1991). Cytomegalovirus and its role in the pathogenesis of acquired immunodeficiency syndrome. Transplant. Proc. 23(Suppl. 3), 118-121.
19. Ho, M. (1991). Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient. Transplant. Proc. 23(Suppl. 1), 2-7.
20. Ibanez, C. E., Schrier, R., Ghazal, P., Wiley, C., and Nelson, J. A. (1991). Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65, 6581-6588.
21. Jacobson, M. A., and Mills, J. (1988). Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 108, 585-594.
22. Jordan, M. C. (1983). Latent infection and the elusive cytomegalovirus. Rev. Infect. Dis. 5, 205-215.
23. Jordan, M. C., and Mar, V. L. (1982). Spontaneous activation of latent cytomegalovirus from murine spleen explants: Role of lymphocytes and macrophages in release and replication of virus. J. Clin. Invest. 70, 762-768.
24. Jordan, M. C., and Pomeroy, C. (1991). Latent CMV infection in the mouse. Transplant. Proc. 23, 17-21.
25. Jordan, M. C., Shanley, J. D., and Stevens, J. G. (1977). Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J. Gen. Virol. 27, 419-423.
26. Keil, G. M., Ebeling-Keil, A., and Koszinowski, U. H. (1987). Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J. Virol. 61, 1901-1908.
27. Kondo, K., Kaneshima, H., and Mocarski, E. S. (1994). Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91, 11879-11883.
28. Lathey, J. L., and Spector, S. A. (1991). Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65, 6371-6375.
29. Mayo, D., Armstrong, J .A., and Ho, M. (1978). Activation of latent murine cytomegalovirus: Cocultivation, cell transfer and the effect of immunosuppression. J. Infect. Dis. 138, 890-896.
30. Mayo, D. R., and Rapp, F. (1980). Leukaemia reactivates mouse cytomegalovirus. J. Gen. Virol. 51, 401-404.
31. Mayo, D. R., Armstrong, J. A., and Ho, M. (1977). Reactivation of murine cytomegalovirus by cyclophosphamide. Nature 267, 721-723.
32. Mercer, J. A., Marks, J. R., and Spector, D. H. (1983). Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith strain). Virology 129, 94-106.
33. Mercer, J. A., Wiley, C. A., and Spector, D. H. (1988). Pathogenesis of murine cytomegalovirus infection: Identification of infected cells in the spleen during acute and latent infections. J. Virol. 62, 987-997.
34. Metcalf, D. (1989). The molecular control of cell division, differentiation commitment and maturation in hemopoietic cells. Nature 339, 27-30.
35. Minton, E. J., Tysoe, C., Sinclair, J. H., and Sissons, J. G. (1994). Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68, 4017-4021.
36. Mitchell, B. M., and Stevens, J. G. (1996). Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response. J. Immunol. 156, 246-255.
37. Percivalle, E., Revello, M. G., Vago, L., Morini, F., and Gerna, G. (1993). Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J. Clin. Invest. 92, 663-670.
38. Pomeroy, C., Hilleren, P. J., and Jordan, M. C. (1991). Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J. Virol. 65, 3330-3334.
39. Revello, M. G., Percivalle, E., Di Matteo, A., Morini, F., and Gerna, G. (1992). Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. J. Gen. Virol. 73, 437-442.
40. Rice, G. P. A., Schrier, R. D., and Oldstone, M. B. A. (1984). Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA 81, 6134-6138.
41. Rinaldo, C. R., Black, P. H., and Hirsch, M. S. (1977). Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus infection. J. Infect. Dis. 136, 667-678.
42. Saltzman, R .L., Quirk, M. R., and Jordan, M. C. (1988). Disseminated cytomegalovirus infection: Molecular analysis of virus and leukocyte interactions in viremia. J. Clin. Invest. 81, 75-81.
43. Schrier, R. D., Nelson, J. A., and Oldstone, M. B. A. (1985). Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 230, 1048-1051.
44. Shanley, J. D., Jordan, M. C., Cook, M. L., and Stevens, J. G. (1979). Pathogenesis of reactivated latent murine cytomegalovirus infection. Am. J. Pathol. 95, 67-80.
45. Smyth, R. L., Sinclair, J., Scott, J. P., Gray, J. J., Higenbottam, T. W., Wreghitt, T. G., Wallwork, J., and Borysiewicz, L. K. (1991). Infection and reactivation with cytomegalovirus strains in lung transplant recipients. Transplantation 52, 480-482.
46. Soderberg, C., Larsson, S., Bergstedt-Lindqvist, S., and Moller, E. (1993). CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J. Virol. 67, 6576-6585.
47. Stannier, P., Taylor, D. L., Kitchen, A. D., Wales, N., Tryhorn, Y., and Tyms, A. S. (1989). Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. Br. Med. J. 299, 897-898.
48. Stoddart, C. A., Cardin, R. D., Boname, J. M., Manning, W. C., Abenes, G. B., and Mocarski, E. S. (1994). Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68, 6243-6253.
49. Taylor-Wiedeman, J., Hayhurst, G. P., Sissons, J. G. P., and Sinclair, J. H. (1993). Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J. Gen. Virol. 74, 265-268.
50. Taylor-Wiedeman, J., Sissons, J. G., Borysiewicz, L. K., and Sinclair, J. H. (1991). Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72, 2059-2064.
51. Taylor-Wedeman, J. A., Sissons, J. G. P., and Sinclair, J. H. (1994). Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68, 1597-1604.
52. Thompson, R. L., and Stevens, J. G. (1983). Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically nonneurovirulent. Virology 131, 171-179.
53. Winston, D. J., Ho, W. G., Howell, C. L., Miller, M. J., Mickey, R., Martin, W. J., Lin, C. H., and Gale, R. P. (1980). Cytomegaovirus infections associated with leukocyte transfusions. Ann. Intern. Med. 93, 671-675.
54. Yeager, A. S., Grumet, F. C., Hafleigh, E. B., Arvin, A. M., Bradley, J. S., and Prober, C. G. (1981). Prevention of transfusion-acquired cytomegalovirus infection in newborn infants. J. Pediatr. 98, 281-287.
55. Yuhasz, S. A., Dissette, V. B., Cook, M. L., and Stevens, J. G. (1994). Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology 202, 272-280.